Identification of patients at risk for developing brain tumors is impo
rtant for the development of preventative strategies. Because individu
als with germline p53 mutations may be at increased risk, we examined
DNA from brain tumor-derived cell lines and malignant and normal nervo
us system tissue for p53 gene mutations using the single strand confor
mation polymorphism assay and direct sequencing of polymerase chain re
action-amplified DNA. We found mutations in the p53 gene in eight of 2
2 adult glioma tissue specimens and germline mutations in two of these
eight patients. In contrast, mutation of the p53 gene was not detecta
ble in either 16 glial tumors occurring in children, glial tumor tissu
e from three unrelated glioblastoma multiforme patients with a familia
l history of cancer, or in benign meningiomas. One constitutional p53
mutation was a G to T transversion at codon 154, and the second was a
C to T transition at codon 256. Both patients with germline mutations
developed glioblastoma multiforme before the age of 31, although the m
edian age for glioma patients is above 50. These findings suggest that
p53 germline mutations may identify a subset of young adults predispo
sed to the development of high-grade astrocytic tumors.